191 related articles for article (PubMed ID: 1431132)
1. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
Darcy F; Maes P; Gras-Masse H; Auriault C; Bossus M; Deslee D; Godard I; Cesbron MF; Tartar A; Capron A
J Immunol; 1992 Dec; 149(11):3636-41. PubMed ID: 1431132
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents.
Angus CW; Klivington-Evans D; Dubey JP; Kovacs JA
J Infect Dis; 2000 Jan; 181(1):317-24. PubMed ID: 10608781
[TBL] [Abstract][Full Text] [Related]
5. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes.
Bülow R; Boothroyd JC
J Immunol; 1991 Nov; 147(10):3496-500. PubMed ID: 1940349
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.
Kasper LH; Khan IA; Ely KH; Buelow R; Boothroyd JC
J Immunol; 1992 Mar; 148(5):1493-8. PubMed ID: 1538132
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
8. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
Khan IA; Ely KH; Kasper LH
J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.
Siachoque H; Guzman F; Burgos J; Patarroyo ME; Gomez Marin JE
Exp Parasitol; 2006 Sep; 114(1):62-5. PubMed ID: 16545806
[TBL] [Abstract][Full Text] [Related]
10. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii.
Kasper LH; Currie KM; Bradley MS
J Immunol; 1985 May; 134(5):3426-31. PubMed ID: 3884710
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
[TBL] [Abstract][Full Text] [Related]
12. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
13. [Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification].
Darcy F; Torpier G; Cesbron-Delauw MF; Decoster A; Ridel PR; Duquesne V; Charif H; Godard I; Pierce RJ; Auriault C
Ann Biol Clin (Paris); 1989; 47(7):451-7. PubMed ID: 2479305
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies.
Kato M; Claveria FG; Maki Y; Sanda K; Tanaka T; Omata Y; Nagasawa H; Suzuki N
Pathobiology; 2007; 74(1):50-6. PubMed ID: 17496433
[TBL] [Abstract][Full Text] [Related]
15. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30].
Yang TT; He SY; Jiang H; Gu QM; Cong H; Zhou HY; Zhang JQ; Li Y; Zhao QL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):14-7. PubMed ID: 16042200
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
[TBL] [Abstract][Full Text] [Related]
18. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
Yin GR; Meng XL; Ma GY; Ma XM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
[TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
Lau YL; Fong MY
Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
